Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors
International Journal of Molecular Sciences · 28.05.2026 · 27 (11) · 4874
DOI: 10.3390/ijms27114874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.05.2026. Verfasst von Jan Musiałkiewicz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznań, Poland. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Mutation, Intestinal Neoplasms. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroendocrine tumors (NETs) constitute a heterogeneous and predominantly malignant group of neuroendocrine neoplasms that arise from endocrine cells dispersed throughout the body. Their clinical presentation, biological behavior, prognosis, and therapeutic management vary considerably depending on the primary tumor location and hormonal activity. Despite substantial progress in understanding the biology of NETs, identifying reliable molecular biomarkers for diagnosis, prognosis, and prediction of treatment response remains a major challenge. Increasing attention has therefore been devoted to the molecular characterization of NETs, with particular focus on recurrent genetic alterations that may contribute to tumor initiation and progression. In this review, we summarize current knowledge and recent findings referring to certain genes involved in the tumorigenesis of pancreatic and intestinal neuroendocrine tumors. We chose the genes based on data from the COSMIC (Catalogue of Somatic Mutations in Cancer) database, which compiles somatic mutations identified across numerous human cancers. We outline the biological functions of these changes and discuss their potential prognostic and predictive role as molecular markers. We also discuss their clinical relevance in both sporadic and familial forms of NETs, alongside their implications for future research and personalized management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznań, Poland.
ORCID-Profile: Jan Musiałkiewicz, Bartłomiej Budny, Adam Maciejewski, Paweł Komarnicki, Marek Ruchała
Zitieren
APA
Musiałkiewicz, J., Budny, B., Anioła, A., Maciejewski, A., Komarnicki, P., Maciejewska, J., Gut, P., & Ruchała, M. (2026). Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors. International Journal of Molecular Sciences, 27(11), 4874. https://doi.org/10.3390/ijms27114874
Vancouver
Musiałkiewicz J, Budny B, Anioła A, Maciejewski A, Komarnicki P, Maciejewska J, et al. Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors. International Journal of Molecular Sciences. 2026;27(11):4874. doi:10.3390/ijms27114874
BibTeX
@article{Musiakiewicz2026,
author = {Musiałkiewicz, Jan and Budny, Bartłomiej and Anioła, Aleksandra and Maciejewski, Adam and Komarnicki, Paweł and Maciejewska, Joanna and Gut, Paweł and Ruchała, Marek},
title = {Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4874},
doi = {10.3390/ijms27114874}
}
EUVIMED